Expression of p16 in ESCC means an active HPV infection in tumor cells and has been shown to correlate with higher rate of pathologic complete remission in patients undergoing neoadjuvant chemotherapy [34], compared with p16 negative individuals, who carry HPV DNA. The gene discussed is CDKN2A; the disease is esophageal squamous cell carcinoma.